Topoisomerase I inhibitors: Challenges, progress and the road ahead.

Talukdar, Arindam; Kundu, Biswajit; Sarkar, Dipayan; Goon, Sunny; Mondal, Mohabul Alam

Talukdar, Arindam; Kundu, Biswajit; Sarkar, Dipayan; Goon, Sunny; Mondal, Mohabul Alam.

Affiliation

Talukdar A; Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata, 700032, WB, India; Academy of Scientific and Innovative Research, Ghaziabad, 201002, India. Electronic address: atalukdar@iicb.res.in.
Kundu B; Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata, 700032, WB, India. Electronic address: biswakundu123@gmail.com.
Sarkar D; Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata, 700032, WB, India; Academy of Scientific and Innovative Research, Ghaziabad, 201002, India.
Goon S; Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata, 700032, WB, India; The Department of Chemistry, Jadavpur University, Kolkata, West Bengal, 700032, India.
Mondal MA; The Department of Chemistry, Jadavpur University, Kolkata, West Bengal, 700032, India.

Eur J Med Chem ; 236: 114304, 2022 Jun 05.

Article de En | MEDLINE | ID: mdl-35413618

Sujet(s)
Mots clés

Antibody-drug conjugates; Combination therapy; Natural source; Structure-activity relationship; Synthetic origin; Topoisomerase IB poisons

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Toxiques / Antinéoplasiques Langue: En Journal: Eur J Med Chem Année: 2022 Type de document: Article Pays de publication: France

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google